Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
Royalty Pharma plc
RPRXFinance
$22B
Market Cap
Shariah Analysis
Failed
Business
Cash
Liabilities
Based on AAOIFI screening standards, Royalty Pharma plc appears to be Failed.
Business Activity
Revenue breakdown data currently unavailable.
Financial Screening
FYE 2024
Cash (<30%)15.96%
Non-Shariah Cash Items
Cash And Cash Equivalents$929M
Other Short Term Investments$842M
Liabilities (<30%)68.60%
Non-Shariah Liabilities
Long Term Debt$6.6B
Current Debt$997.8M
Market Data
Exchange
NASDAQ
CurrencyUSD
CountryUnited States
Last Updated2025-12-15
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.
NASDAQ
